Bottom line
How much do BBH and RYOIX overlap?
64% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 85.4% of BBH's assets and 40.3% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
RYOIX holds far more positions (74 vs 25), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings BBH and RYOIX have in common
| Holding | % of BBH | % of RYOIX | Overlap |
|---|---|---|---|
| Amgen Inc | 15.25% | 5.05% | 5.05% |
| Gilead Sciences Inc | 12.79% | 4.49% | 4.49% |
| Vertex Pharmaceuticals Inc | 9.10% | 4.32% | 4.32% |
| Regeneron Pharmaceuticals Inc | 6.21% | 2.93% | 2.93% |
| Revolution Medicines Inc | 5.27% | 2.48% | 2.48% |
| Argenx SE | 4.97% | 1.48% | 1.48% |
| Natera Inc | 4.92% | 2.12% | 2.12% |
| Alnylam Pharmaceuticals Inc | 3.83% | 2.36% | 2.36% |
| Biogen Inc | 3.63% | 2.13% | 2.13% |
| Moderna Inc | 3.36% | 2.15% | 2.15% |
| Illumina Inc | 3.17% | 1.94% | 1.94% |
| United Therapeutics Corp | 2.83% | 1.72% | 1.72% |
| BeOne Medicines Ltd | 2.81% | 2.17% | 2.17% |
| Insmed Inc | 2.67% | 1.79% | 1.79% |
| Incyte Corp | 2.49% | 1.62% | 1.62% |
| Neurocrine Biosciences Inc | 2.08% | 1.52% | 1.52% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in BBH
- IQVIA Holdings Inc — 4.31%
- BioNTech SE — 1.94%
- Icon Plc — 1.90%
- Bio-Techne Corp — 1.54%
- Charles River Laboratories International Inc — 1.50%
- BioMarin Pharmaceutical Inc — 1.34%
- Qiagen Nv — 1.06%
- Tempus AI Inc — 0.98%
- State Street Global Advisors — 0.06%
Only in RYOIX
- Abbvie Inc — 8.17%
- Royalty Pharma Plc — 2.01%
- Guardant Health Inc — 1.72%
- Roivant Sciences Ltd — 1.66%
- Viatris Inc — 1.55%
- Jazz Pharmaceuticals Plc — 1.42%
- Bridgebio Pharma Inc — 1.38%
- Ionis Pharmaceuticals Inc — 1.35%
- Cytokinetics Inc — 1.35%
Asset mix
| Asset type | BBH | RYOIX |
|---|---|---|
| Stocks | 100.0% | 99.6% |
| Repurchase agreements | — | 0.6% |
| Cash & short-term funds | 0.1% | 0.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | BBH | RYOIX |
|---|---|---|
| US | 87.3% | 85.8% |
| NL | 6.0% | 1.5% |
| CH | 2.8% | 3.3% |
| GB | — | 3.2% |
| IE | 1.9% | 2.7% |
| DE | 1.9% | 1.2% |
| BM | — | 1.7% |
| DK | — | 0.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do BBH and RYOIX overlap?
What stocks do BBH and RYOIX have in common?
Should I own both BBH and RYOIX?
Which holds more stocks, BBH or RYOIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.